| Description | Ormutivimab (rhRIG), a recombinant human monoclonal antibody designed to target the rabies virus, effectively neutralizes various strains and demonstrates strong efficacy as a post-exposure prophylaxis (PEP) treatment in model studies [1] [2]. |
| In vivo | Ormutivimab（20 IU/kg；肌肉注射；单剂量）能有效防护比格犬免遭RABV BD06致命性侵害[1]。对于Kunming小鼠，Ormutivimab（20 IU/kg及100 IU/kg；肌注；单剂量）同样展现了对抵御多种狂犬病病毒的保护作用[1]。 |
| Synonyms | rhRIG, NM57 |
| molecular weight | N/A |
| CAS | 2449086-91-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |